NextFin News - Two of India's newest listed companies opened as much as 63% above their IPO prices on August 19, 2026, a splashy double debut for metal-rolls maker Behari Lal Engineering and e-commerce logistics platform Shiprocket. The pops arrive just as the National Stock Exchange of India prepares its own long-awaited public offering, and they frame the central question for the bourse's roughly $3 billion listing: is there enough depth in India's primary market to absorb a $57 billion exchange at the same time as a record pipeline of corporate debuts?
The answer matters because the two stories point in opposite directions. The exchange that runs India's listings is itself trying to list at a moment when its own core revenue engine — equity derivatives — has been deliberately cooled by regulators. The August 19 debuts are the market's first real signal that demand for new paper can carry both.
Two Pops, One Flat Index: What August 19 Actually Showed
Behari Lal Engineering, a maker of metal rolls used in steel production, priced its ₹301.62 crore ($34.5 million) issue at ₹285 a share after bidding closed on August 14. The stock opened at ₹465 on the NSE on August 19 — up ₹180, or 63.16%, against the issue price. Behari Lal, assessed by CRISIL as one of India's largest metal-rolls producers, drew a heavily oversubscribed book, with the qualified-institutional-buyer portion going more than 165 times.
Shiprocket listed the same morning at a 35% premium over its ₹92–₹97 price band in a ₹1,617.48 crore offering. That premium is the more telling of the two. Shiprocket is not yet profitable on a net basis: it posted a net loss of ₹74 crore in the year ended March 2025, trimmed to ₹38.3 crore in the first half of fiscal 2026 even as operating revenue rose 15% to ₹942.7 crore. A loss-making logistics platform still commanding a 35% first-day premium is not a market betting on index beta. It is a market hunting for specific stories.
The strength was not isolated. India's primary market recorded 44 listings across the NSE and BSE in the first half of 2026, with an average listing-day gain of 6.56% as of late June. Small and mid-cap enterprise (SME) issues outperformed the mainboard, where the average listing gain was a more modest 1.68%. The dispersion between winners and losers was wide — OnEMI Technology (Kissht) gained 59.3% on its May 8 debut, Vegorama Punjabi Angithi 53.4% in late May, RFBL Flexi Pack 40.5%, Powerica 40% — but the median signal is clear: retail and institutional appetite for new issues remains intact even while the benchmark Nifty traded sideways near 24,100 and small- and mid-cap shares were broadly lower on the day.
That appetite is the backdrop for the most important listing still to come. The National Stock Exchange of India, the operator of the world's largest derivatives exchange by trading volume, is targeting a September IPO and began formal marketing in early July, according to people familiar with the matter. The exchange plans investor meetings across the US, London, Singapore, Hong Kong, the Middle East and India, and is seeking to raise as much as $3 billion. At a discussed price of around ₹1,900 per share, the issue would be worth about $3.3 billion and value NSE at roughly $57 billion — which would make it the world's fifth-most valuable exchange, behind London Stock Exchange Group. Unlisted NSE shares currently trade near ₹2,000, or about $21.18, implying the higher valuation.
Here is the tension. NSE's revenue more than doubled between April 2019 and April 2026 to about ₹187 billion, powered by India's options-trading boom. But that boom is now a regulated one. The Securities and Exchange Board of India has spent the past year tightening rules on equity derivatives — higher entry thresholds, wider contract sizes, fewer weekly expiries — to cool what it viewed as excessive retail speculation. NSE disclosed in its IPO papers that growth has slowed over the past year after those curbs, and warned that revenue
"could continue to be impacted by government and regulatory measures aimed at tempering derivatives activity."
The exchange that is about to sell a growth story to public investors is selling it on a franchise whose fastest-growing line item has been structurally throttled.
Why Listing Pops Matter More to an Exchange Than to a Stock Picker
A 63% first-day pop is not, by itself, evidence of a healthy market. It can signal underpricing just as easily as genuine demand. The more informative read is the pattern around it: a loss-making logistics company still found buyers at a 35% premium; SME issues kept outperforming the mainboard; and the average listing gain held above 6% even as the Nifty failed to make new highs. That combination points to a market that is stock-specific rather than index-driven — investors are chasing idiosyncratic stories, not broad beta.
For an exchange, that distinction is everything. NSE earns fees on turnover, not on the level of the index. A flat Nifty with high stock dispersion can produce more order flow than a grinding bull market in which everyone holds the same handful of index weights. Fresh listings add tradable names, generate volatility around debuts, and give retail brokers a reason to push clients back into the market. The pipeline supports the point: more than 190 companies are either approved or awaiting clearance, representing a potential fundraising pool exceeding ₹2.5 lakh crore (about $28–30 billion), according to Prime Database data compiled by IPO trackers. Of those, 84 companies hold SEBI approval to raise about ₹1.14 lakh crore, with another 108 in the queue for a projected ₹1.46 lakh crore.
The transmission mechanism is often misstated. It is not "hot IPOs make the exchange rich." Listing fees are a small, one-time line. The real channel runs through the secondary market: a deep primary pipeline keeps the inventory of tradable stories replenished, which sustains the cash-equity turnover that funds NSE's revenue even as derivatives volumes contract. In that sense, every successful debut in August is a data point for NSE's September marketing deck — evidence that the market it operates can still clear new supply without breaking.
The Derivatives Slowdown Is Structural, Not Cyclical
The bear case against NSE starts with hard numbers. At its peak, India's premium traded in equity options was still only 35% of the US options premium in 2025, and total US options turnover rose 39% to $9,332 billion last year, according to data from the Options Clearing Corporation and NSE Market Pulse cited by the exchange. A single S&P 500 options contract carries a notional value more than 31 times that of a Nifty 50 contract. India's derivatives dominance, in other words, is a dominance of contract count, not of notional value — and the contract count is now a regulated variable.
SEBI's response to the retail-speculation risk was structural, not cyclical. The regulator did not pause the market; it rewrote the rules. Higher minimum ticket sizes, wider lot sizes, and consolidated expiries do not reverse when sentiment improves. They permanently raise the cost of doing the business that made NSE rich over the past seven years. In its filing, NSE warned that revenue could continue to be impacted by such measures. Read plainly, that is management telling investors, in required-disclosure language, that the fastest-growing line item of the past cycle is now a regulated utility rather than a growth engine.
This is the crux of the cyclical-versus-structural call, and getting it wrong flips the investment conclusion. The IPO market's current warmth is largely cyclical. It rides retail liquidity, risk appetite, and a queue of companies that delayed listings until conditions improved. It will mean-revert when valuations stretch or when a few high-profile debuts break. The derivatives curb, by contrast, is structural. It is a regime change in the rules of the game, and it will not self-correct on its own. Any investor underwriting NSE at a $57 billion valuation is implicitly betting that cash-equity turnover, first-time investor growth, and new products can fill a gap that derivatives once filled — and do it fast enough to justify a premium multiple.
There is, however, a quiet offset that the bear case often misses: pricing power. NSE is a natural monopoly in Indian equity derivatives. Even with lower volumes, an exchange that owns the order flow can defend revenue by raising the take rate — up to the point where regulators object. The derivatives book may shrink in volume without shrinking proportionally in profit. That is the difference between a utility and a declining asset, and it is the argument NSE's bankers will lean on hardest.
What NSE Is Actually Selling
NSE's growth pitch, in its own words from the IPO papers, is that expansion
"will hinge on continued expansion in first-time investors, rising trading activity, innovation in derivatives products and a push into commodities."
Read that sentence closely. Three of the four pillars — first-time investors, rising activity, innovation in derivatives — depend on the same retail participation that SEBI is trying to moderate. Only the commodities push is a genuinely new market, and it is not yet large enough to carry the growth story on its own.
The exchange will also emphasize scarcity and access. NSE has about 180,000 shareholders currently, and its shares are among the most closely watched unlisted names in India. The offering is entirely an offer-for-sale of up to 148.9 million shares, representing nearly 6% of paid-up capital — no fresh capital goes to the exchange itself. The top 10 selling investors are set for a combined windfall of about $2.6 billion based on acquisition prices disclosed in the draft prospectus. The seller group includes State Bank of India, Singapore's GIC, Canada's CPPIB, Temasek Holdings, LIC and Morgan Stanley. For those holders, after years of regulatory delays that kept the IPO shelved since 2016, the August listing warmth is a timing gift.
There is also the matter of the co-location case. NSE's listing was blocked for years by litigation with the markets regulator, but the exchange moved closer to launch after SEBI agreed to a ₹1,491.21 crore settlement of the co-location dispute. With that overhang cleared and the DRHP filed, the remaining gating item is simply market conditions — which is exactly what the August 19 pops were meant to test.
Pricing is being calibrated to clear. Sources have said the IPO may be offered at a 5% to 10% discount to private-market valuations, around ₹1,900 per share.
"At this valuation NSE would attract incoming investors while not short-changing existing ones,"one merchant banker said. A modest discount to the unlisted price is the oldest tool for engineering a clean debut — and for giving the exchange's own listing the kind of first-day pop that Behari Lal and Shiprocket delivered.
The Counter-Thesis: The Pipeline Is Supply, Not Demand
The strongest argument against the optimistic read is simple: a backlog of 190 companies is not demand, it is supply. India's 2021–2022 IPO boom ended with a hangover of broken debuts that took years to recover. If the market is asked to absorb ₹2.5 lakh crore of new paper over 18 months, and several flagship names land in the same window — Reliance Industries' digital arm Jio Platforms is reportedly weighing an offering estimated between ₹30,000 crore and ₹52,000 crore, Walmart-backed PhonePe is expected to seek about $1.2–1.5 billion, and SBI Funds Management is targeting roughly $1.2 billion — the primary market can flood. When that happens, the 6.56% average listing gain compresses, the pops disappear, and NSE's own listing timing becomes the test rather than the beneficiary.
There is also concentration risk on the buy side. The top 10 shareholders are exiting; the buyers are being asked to write a $3 billion check for an asset whose primary growth driver is under regulatory pressure. If domestic mutual funds and insurers are already stretched absorbing the corporate pipeline, the price at which NSE can clear its offering may be lower than the ₹1,900 anchor being discussed. The counter-thesis is not that NSE is a bad asset — it is a monopoly-grade franchise with strong cash generation. It is that August's listing pops prove demand exists for small and mid-sized stories; they do not prove that demand is deep enough for a $57 billion exchange debut in September.
The falsifying signal is concrete. This analysis rests on the claim that primary-market demand is broad enough to carry both a deep corporate pipeline and a mega exchange listing without repricing. Watch the subscription levels and listing-day performance of the next three mainboard IPOs after August 19. If two or more list flat or negative while overall market breadth stays neutral, the "strong demand" narrative is confined to small issues, and NSE's September window becomes materially riskier. If mainboard pops hold above 15% through September, the market has the depth the exchange's valuation assumes.
Outlook: Three Scenarios for the Exchange's Own Debut
In the short term, the August 19 debuts hand NSE's marketing team a tangible talking point: the primary market they operate is functioning, listings are rewarded, and India's equity story still attracts order flow even in a range-bound index. That supports a clean September debut, likely with the discussed 5%–10% discount baked in to guarantee a first-day gain. The near-term asymmetry favors the sellers.
Medium-term, the picture is more mixed. NSE's earnings growth will no longer trace a straight line upward. The derivatives segment that doubled the revenue base in seven years is now a regulated, slower-growth franchise. Offsetting that are three genuine supports: natural-monopoly pricing power in equity derivatives, the commodities-expansion option, and a primary-market pipeline that, if executed without a flood of broken debuts, keeps secondary turnover alive. The base case is mid-teens revenue growth with margin resilience, not the 20%-plus trajectory of the 2019–2026 cycle.
Long-term, the structural question is whether India's retail participation can grow fast enough to outpace regulatory tightening. If first-time demat accounts keep expanding and the exchange successfully launches new products — including in commodities — the $57 billion valuation can be grown into. If SEBI's next phase of curbs goes further, the multiple will compress regardless of how well August's listings performed.
The scenarios break down as follows:
- Base case: NSE lists in September at ₹1,800–₹1,900 per share, raises about $3 billion, and trades flat to modestly higher in its first year as derivatives volumes stabilize.
- Upside case: mainboard IPO pops stay strong, SEBI signals a pause in new curbs, and the commodities push gains traction — the stock rerates toward the unlisted ₹2,000 level.
- Downside case: two or more large mainboard debuts break, primary demand cools, and the IPO prices at a deeper discount or slips after listing as investors reprice derivatives exposure.
The beneficiaries are clear: existing shareholders cashing out at a premium to book, the investment banks running the deal, and a domestic investor base gaining access to a scarce, monopoly-grade asset. The exposed are investors who underwrite the derivatives growth rate of 2019–2026 into a 2027–2030 model.
India's listings are sparkling, but the exchange selling them is being asked to grow on one engine while regulators keep their foot on the other. The August pops prove demand exists; they do not prove it is deep enough for a $57 billion debut.
Data as of August 19, 2026 for listing performance; NSE IPO marketing status as of early July 2026. Currency conversions at approximately ₹87.5 to the dollar.
Explore more exclusive insights at nextfin.ai.
